Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study

Blanche P. Alter, Neelam Giri, Sharon A. Savage, June A. Peters, Jennifer T. Loud, Lisa Leathwood, Ann G. Carr, Mark H. Greene, Philip S. Rosenberg

Research output: Contribution to journalArticle

Abstract

Fanconi anaemia (FA), dyskeratosis congenita (DC), Diamond-Blackfan anaemia (DBA), and Shwachman-Diamond syndrome (SDS) comprise major inherited bone marrow failure syndromes (IBMFS). Adverse events include severe bone marrow failure (BMF), myelodysplastic syndrome (MDS), acute myeloid leukaemia (AML), and solid tumours (ST). The natural history of FA is well characterised; hazard rates in the other syndromes have not yet been quantified. An open cohort was established at the National Cancer Institute (NCI) in 2002. Patients enrolled prior to December, 2007 were followed up to December, 2008. Diagnoses were confirmed with standard tests. Age-associated risks of adverse events were calculated. Most patients in each syndrome survived to young adulthood. Patients with FA had earlier onset of cancers, need for stem cell transplant, and death; followed by DC; DBA and SDS were mildest. While FA and DC patients had markedly increased risks of cancer, AML and MDS, there were no cases of leukaemia in DBA or SDS patients. The NCI cohort provides the first direct quantitative comparison of timing and magnitude of cancer risk in the IBMFS. The findings demonstrate that both FA and DC are major cancer susceptibility syndromes. The IBMFS, historically considered paediatric disorders, have important management implications for physicians treating adult patients.

Original languageEnglish (US)
Pages (from-to)179-188
Number of pages10
JournalBritish Journal of Haematology
Volume150
Issue number2
DOIs
StatePublished - Jul 2010
Externally publishedYes

Fingerprint

National Cancer Institute (U.S.)
Fanconi Anemia
Dyskeratosis Congenita
Cohort Studies
Diamond-Blackfan Anemia
Survival
Neoplasms
Myelodysplastic Syndromes
Acute Myeloid Leukemia
Neoplastic Stem Cells
Bone Marrow failure syndromes
Leukemia
Cell Death
Pediatrics
Physicians
Transplants
Shwachman syndrome

Keywords

  • bone marrow failure
  • dyskeratosis congenita
  • Fanconi anaemia
  • leukaemia
  • solid tumours

ASJC Scopus subject areas

  • Hematology

Cite this

Alter, B. P., Giri, N., Savage, S. A., Peters, J. A., Loud, J. T., Leathwood, L., ... Rosenberg, P. S. (2010). Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study. British Journal of Haematology, 150(2), 179-188. https://doi.org/10.1111/j.1365-2141.2010.08212.x

Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study. / Alter, Blanche P.; Giri, Neelam; Savage, Sharon A.; Peters, June A.; Loud, Jennifer T.; Leathwood, Lisa; Carr, Ann G.; Greene, Mark H.; Rosenberg, Philip S.

In: British Journal of Haematology, Vol. 150, No. 2, 07.2010, p. 179-188.

Research output: Contribution to journalArticle

Alter, BP, Giri, N, Savage, SA, Peters, JA, Loud, JT, Leathwood, L, Carr, AG, Greene, MH & Rosenberg, PS 2010, 'Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study', British Journal of Haematology, vol. 150, no. 2, pp. 179-188. https://doi.org/10.1111/j.1365-2141.2010.08212.x
Alter, Blanche P. ; Giri, Neelam ; Savage, Sharon A. ; Peters, June A. ; Loud, Jennifer T. ; Leathwood, Lisa ; Carr, Ann G. ; Greene, Mark H. ; Rosenberg, Philip S. / Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study. In: British Journal of Haematology. 2010 ; Vol. 150, No. 2. pp. 179-188.
@article{8f83d28d260d4e65b8a90fe9793119aa,
title = "Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study",
abstract = "Fanconi anaemia (FA), dyskeratosis congenita (DC), Diamond-Blackfan anaemia (DBA), and Shwachman-Diamond syndrome (SDS) comprise major inherited bone marrow failure syndromes (IBMFS). Adverse events include severe bone marrow failure (BMF), myelodysplastic syndrome (MDS), acute myeloid leukaemia (AML), and solid tumours (ST). The natural history of FA is well characterised; hazard rates in the other syndromes have not yet been quantified. An open cohort was established at the National Cancer Institute (NCI) in 2002. Patients enrolled prior to December, 2007 were followed up to December, 2008. Diagnoses were confirmed with standard tests. Age-associated risks of adverse events were calculated. Most patients in each syndrome survived to young adulthood. Patients with FA had earlier onset of cancers, need for stem cell transplant, and death; followed by DC; DBA and SDS were mildest. While FA and DC patients had markedly increased risks of cancer, AML and MDS, there were no cases of leukaemia in DBA or SDS patients. The NCI cohort provides the first direct quantitative comparison of timing and magnitude of cancer risk in the IBMFS. The findings demonstrate that both FA and DC are major cancer susceptibility syndromes. The IBMFS, historically considered paediatric disorders, have important management implications for physicians treating adult patients.",
keywords = "bone marrow failure, dyskeratosis congenita, Fanconi anaemia, leukaemia, solid tumours",
author = "Alter, {Blanche P.} and Neelam Giri and Savage, {Sharon A.} and Peters, {June A.} and Loud, {Jennifer T.} and Lisa Leathwood and Carr, {Ann G.} and Greene, {Mark H.} and Rosenberg, {Philip S.}",
year = "2010",
month = "7",
doi = "10.1111/j.1365-2141.2010.08212.x",
language = "English (US)",
volume = "150",
pages = "179--188",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study

AU - Alter, Blanche P.

AU - Giri, Neelam

AU - Savage, Sharon A.

AU - Peters, June A.

AU - Loud, Jennifer T.

AU - Leathwood, Lisa

AU - Carr, Ann G.

AU - Greene, Mark H.

AU - Rosenberg, Philip S.

PY - 2010/7

Y1 - 2010/7

N2 - Fanconi anaemia (FA), dyskeratosis congenita (DC), Diamond-Blackfan anaemia (DBA), and Shwachman-Diamond syndrome (SDS) comprise major inherited bone marrow failure syndromes (IBMFS). Adverse events include severe bone marrow failure (BMF), myelodysplastic syndrome (MDS), acute myeloid leukaemia (AML), and solid tumours (ST). The natural history of FA is well characterised; hazard rates in the other syndromes have not yet been quantified. An open cohort was established at the National Cancer Institute (NCI) in 2002. Patients enrolled prior to December, 2007 were followed up to December, 2008. Diagnoses were confirmed with standard tests. Age-associated risks of adverse events were calculated. Most patients in each syndrome survived to young adulthood. Patients with FA had earlier onset of cancers, need for stem cell transplant, and death; followed by DC; DBA and SDS were mildest. While FA and DC patients had markedly increased risks of cancer, AML and MDS, there were no cases of leukaemia in DBA or SDS patients. The NCI cohort provides the first direct quantitative comparison of timing and magnitude of cancer risk in the IBMFS. The findings demonstrate that both FA and DC are major cancer susceptibility syndromes. The IBMFS, historically considered paediatric disorders, have important management implications for physicians treating adult patients.

AB - Fanconi anaemia (FA), dyskeratosis congenita (DC), Diamond-Blackfan anaemia (DBA), and Shwachman-Diamond syndrome (SDS) comprise major inherited bone marrow failure syndromes (IBMFS). Adverse events include severe bone marrow failure (BMF), myelodysplastic syndrome (MDS), acute myeloid leukaemia (AML), and solid tumours (ST). The natural history of FA is well characterised; hazard rates in the other syndromes have not yet been quantified. An open cohort was established at the National Cancer Institute (NCI) in 2002. Patients enrolled prior to December, 2007 were followed up to December, 2008. Diagnoses were confirmed with standard tests. Age-associated risks of adverse events were calculated. Most patients in each syndrome survived to young adulthood. Patients with FA had earlier onset of cancers, need for stem cell transplant, and death; followed by DC; DBA and SDS were mildest. While FA and DC patients had markedly increased risks of cancer, AML and MDS, there were no cases of leukaemia in DBA or SDS patients. The NCI cohort provides the first direct quantitative comparison of timing and magnitude of cancer risk in the IBMFS. The findings demonstrate that both FA and DC are major cancer susceptibility syndromes. The IBMFS, historically considered paediatric disorders, have important management implications for physicians treating adult patients.

KW - bone marrow failure

KW - dyskeratosis congenita

KW - Fanconi anaemia

KW - leukaemia

KW - solid tumours

UR - http://www.scopus.com/inward/record.url?scp=77954339095&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954339095&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2141.2010.08212.x

DO - 10.1111/j.1365-2141.2010.08212.x

M3 - Article

C2 - 20507306

AN - SCOPUS:77954339095

VL - 150

SP - 179

EP - 188

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 2

ER -